Clinical Trials Browser

Enrolling by invitation × Esophageal Squamous Cell Carcinoma × 1 year × Clear all

NCT07312578 2025-12-31

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

Phase 2 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06984055 2025-05-22

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma